Medigen is an independent vaccine company developing vaccines against emerging infectious diseases and chronic diseases including cancer. Our vaccines are based on unique, proprietary technologies designed to elicit safe, natural immune responses for efficient, long-term immunity.
We apply scientific knowledge of viruses, processes and immune system to discover, develop and commercialize new biopharmaceutical products for treatment and prevention of emerging infections and chronic diseases including cancer.
Founded in 2004, Medigen is a fully integrated vaccine company, headquartered in Frederick, Maryland, 40 miles from Washington, DC.
“By the help of microscopes, there is nothing so small, as to escape our inquiry”